Vancouver, British Columbia, March 04, 2021 (GLOBE NEWSWIRE) -- The global research antibodies market is projected to acquire up to USD 5,325.8 Million by 2027, registering a CAGR of 5.9% over the forecast period. The surging incidences of infectious diseases globally and the increasing applications of research antibodies in neurobiology, oncology, immunology, and stem cells are the pivotal factors fueling the growth of the global research antibodies market. A significant spike in pharmaceutical and biotechnological research activities, substantial government funds and grants for academic & research institutes, and the rising research collaborations between prestigious universities and healthcare giants have stimulated the market growth significantly over recent years.
Antibodies are protein molecules comprising B cells and play an integral role in safeguarding the body’s immune system. One of the most vital functions of antibodies is to identify foreign substances like antigens and aid in fighting infections. Antibodies are considered ideal probes in cell research due to their unique ability to bind to specific molecules. Moreover, they have emerged as an essential tool in the study of cell protein functions.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/192
The constant growth of the global research antibodies market can be further attributed to the technological advancements in antibody development, the growing prevalence of neurodegenerative diseases, such as Multiple Sclerosis (MS), Parkinson’s disease, and Huntington’s disease, and the rising need for effective therapies for such severe health conditions. The growing geriatric population and the exponentially rising number of cancer patients worldwide have further boosted the market growth. The deepening focus on drug development and hefty investments by the government in genomic and proteomic research programs create more opportunities for global market growth in the near future.
The ongoing COVID-19 pandemic has positively impacted the global research antibodies market, as pharmaceutical companies are increasingly focusing on developing monoclonal antibodies for COVID-19 treatment. Monoclonal antibodies are antibodies developed by the cloning of a white blood cell. They emulate the functions of natural antibodies in response to various infections and find significant usage in cancer treatment. In 2020, pharmaceutical giant AstraZeneca commenced the early-stage trial of AZD7442, its antibody-based therapeutics for COVID-19treatment.
The leading healthcare companies, Regeneron and Roche, also collaborated on clinical trials of the monoclonal antibody, called REGN-COV2, which they developed for COVID-19 prevention and treatment.
Key Highlights of the Report:
- Based on product type, the primary antibodies sub-segment is expected to lead the market in terms of revenue over the projected timeline. In immunoassays, primary antibodies play a crucial role as they bind to the target antigens and fight infections efficiently.
- Based on application, the oncology sub-segment is poised to dominate the global market with the highest revenue share over the projected period. The surging prevalence of cancer across the globe, rising investments in stem cell research, and the escalating demand for effective cancer therapeutics bolster this segment’s growth.
- The Asia Pacific market is poised to register the fastest CAGR of 7.1% over the forecast period, primarily owing to the region’s booming pharmaceutical sector and a significant rise in healthcare research & development programs.
- Becton, Dickinson and Company, F.Hoffmann-La Roche AG, Agilent Technologies, Abcam PLC, PerkinElmer, Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Merck Millipore, Cell Signaling Technology Inc., and Lonza Group are the leading market players.
Check Our Prices@ https://www.emergenresearch.com/select-license/192
For the purpose of this report, the global research antibodies market is segmented on the basis of antibody type, product type, application, technology, end-user, and region:
By Antibody Type (Revenue, USD Million; 2017-2027)
- Monoclonal
- Polyclonal
By Product Type (Revenue, USD Million; 2017-2027)
- Primary Antibodies
- Secondary Antibodies
By Application (Revenue, USD Million; 2017-2027)
- Oncology
- Infectious Diseases
- Stem Cells
- Neurobiology
- Immunology
- Others
By Technology (Revenue, USD Million; 2017-2027)
- Western Blotting
- Flow Cytometry
- Immunofluorescence
- Immunohistochemistry
- Enzyme-linked Immunosorbent Assay
- Immunoprecipitation
- Others
By End-user (Revenue, USD Million; 2017-2027)
- Pharmaceutical & Biopharmaceutical Firms
- Academic & Research Institutes
- Contract Research Organizations
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/research-antibodies-market
By Region (Revenue, USD Billion; 2017-2027)
North America
• U.S.
• Canada
Europe
• Germany
• U.K.
• France
• BENELUX
• Rest of Europe
Asia Pacific
• China
• Japan
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Rest of Latin America
Middle East & Africa
• Saudi Arabia
• U.A.E.
• Rest of Middle East & Africa
Take a Look at our Related Reports:
Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions
Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region
Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region
Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027
Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-research-antibodies-market